[DOI] [PubMed] [Google Scholar] 105.Rodrigues F.S., Souza M.A., Magni D.V., Ferreira A.P., Mota B.C., Cardoso A.M., Paim M., Xavier L.L., Ferreira J., Schetinger M.R., Da Costa J.C., Royes L.F., Fighera M.R
10.3896/ibra.1.53.4.13 10 AliM
Recent News & Disruption in the Space:- July 2026 Eli Lilly and Companys Retatrutide Phase III Trials Gain Massive Momentum: Mid-2026 updates show that Eli Lilly's blockbuster-in-waiting, retatrutide (a triple GIP/GLP-1/glucagon receptor agonist), is fast-tracking through its TRIUMPH-2 Phase III trial for Type 2 Diabetes, aiming to significantly eclipse existing dual-agonist outcomes
Examples of insoluble fiber include nuts, potatoes with skin, and brown rice
PMCID: PMC5038610
TABLE 2